With multiple treatments available for many mental health conditions, it’s vitally important we know which will work best for each individual.
Faced with multiple treatment options – such as medication or cognitive behavioural therapy for depression – mental health professionals usually rely on a combination of clinical intuition and recent research.
But what if this process could be made more systematic? That’s the question that the team at the University of Pennsylvania is looking to answer.
Using cutting-edge statistical modelling, our researchers are analysing:
From this, they’ve developed an analytical model that produces a ‘Personalised Advantage Index’ (PAI) – listing the likely impact of treatment options for each patient.
To test and refine the PAI, they’re looking at existing largescale treatment studies – and comparing the treatments that actually worked best with the ones a PAI would have recommended. The next step is to test the PAI in new trials, to see just how effective it can really be.
It can take months or years for doctors to find a mental health treatment that works, with patients not only seeing little improvement but also having to deal with side effects.
The PAI could transform this situation – making individually tailored mental health care a reality, and enabling patients and doctors to choose the best treatments together.
Dr Robert DeRubeis is a professor at the University of Pennsylvania. He specialises in increasing understanding of how depression treatments work.
Do natural variations in hormones, such as oestrogen, make anxiety disorders more likely? If so does this affect the way people respond to treatment?
Dr Lussier aims to determine the extent to which child and adolescent depression interacts with genetic susceptibility to influence suicide risk in early adulthood.
People with severe mental illnesses are at high risk of heart disease due to lack of physical activity and social isolation. Social prescribing can help, but is it accessible?